Intended for healthcare professionals

News

HIV drug under review as firm withdraws FDA application

BMJ 2002; 324 doi: https://doi.org/10.1136/bmj.324.7341.807/a (Published 06 April 2002) Cite this as: BMJ 2002;324:807